Prostate Cancer

Androgen deprivation therapy and the risk of iron-deficiency anaemia among patients with prostate cancer: a population-based cohort study. April 3, 2020

Expansile cribriform Gleason pattern 4 has histopathologic and molecular features of aggressiveness and greater risk of biochemical failure compared to glomerulation Gleason pattern 4. April 3, 2020

BRCA1 and VDR gene polymorphisms are associated with prostate cancer risk in Mexican men. April 3, 2020

Validation of the PI-RADS language: predictive values of PI-RADS lexicon descriptors for detection of prostate cancer. April 3, 2020

Using clinical parameters to predict prostate cancer and reduce the unnecessary biopsy among patients with PSA in the gray zone. April 2, 2020

18F-DCFPyL PET/CT in Patients with Subclinical Recurrence of Prostate Cancer: Effect of Lesion Size, Smooth Filter and Partial Volume Correction on Prostate Cancer Molecular Imaging Standardized Evaluation (PROMISE) criteria. April 2, 2020

Cabazitaxel in patients aged ≥80 years with castration-resistant prostate cancer: Results of a post-marketing surveillance study in Japan. April 2, 2020

Contamination in control group led to no effect of PSA-based screening on prostate cancer mortality at 9 years follow-up: Results of the French section of European Randomized Study of Screening for Prostate Cancer (ERSPC). April 2, 2020

Exploratory Factor Analysis of a Patient-Centered Cancer Care Measure to Support Improved Assessment of Patients' Experiences. April 2, 2020

Prognostic value of the bone scan index in patients with metastatic castration-resistant prostate cancer: a systematic review and meta-analysis. April 2, 2020

Oligometastatic and Oligoprogression Disease and Local Therapies in Prostate Cancer. April 1, 2020

Antitumor activity of ipatasertib combined with chemotherapy: results from a phase Ib study in solid tumors. April 1, 2020

A phase I dose-escalation study of enzalutamide in combination with the AKT inhibitor AZD5363 (capivasertib) in patients with metastatic castration-resistant prostate cancer. April 1, 2020

A novel stratification framework for predicting outcome in patients with prostate cancer. April 1, 2020

Plasma cell-free DNA-based predictors of response to abiraterone acetate/prednisone and prognostic factors in metastatic castration-resistant prostate cancer. April 1, 2020

Targeted α-Therapy in Cancer Management: Synopsis of Preclinical and Clinical Studies. April 1, 2020

DNA repair gene polymorphisms, tumor control, and treatment toxicity in prostate cancer patients treated with permanent implant prostate brachytherapy. April 1, 2020

Muscarinic receptors promote castration-resistant growth of prostate cancer through a FAK-YAP signaling axis. March 31, 2020

(S)-3-(Carboxyformamido)-2-(3-(carboxymethyl)ureido)propanoic Acid as A Novel PSMA Targeting Scaffold for Prostate Cancer Imaging. March 31, 2020

Introduction to special section on: current topics in cancer survivorship and work. March 31, 2020

Page 1 of 1061